The Big Picture: Web technology proliferates in PACS
The Big Picture:Web technology proliferates in PACSBy Erik L. Ridley, EditorThe use of the World Wide Web in the PACS realm continues to expand, and many vendors are devoting increasing resources to bringing these capabilities to their product
The Big Picture:
Web technology proliferates in PACS
By Erik L. Ridley, Editor
The use of the World Wide Web in the PACS realm continues to expand, and many vendors are devoting increasing resources to bringing these capabilities to their product lines. One company, eMed Technologies (formerly Access Radiology) even changed its name in recognition of the increasing role the Internet plays in its future.
Other firms are also moving aggressively to add Web and complementary technologies. They include Merge Technologies, which has signed a letter of intent to acquire Interpra Medical Imaging. Merge believes that Interpras products will find a solid niche in the dawning era of integrated image and information management systems.
Additionally, MR imaging center chain Medical Device Technologies has signed a letter of intent to acquire a stake in Total Information Management Systems. MDT hopes to take advantage of the firms Web-based software to improve efficiency among its imaging centers.
With vendors adopting this technology at a rapid pace, the Web continues to solidify its role in the digital image management sector.
In other news, Ill be moving on to a new post as editor of our sister publication, Diagnostic Imaging SCAN. Taking over as editor of PACS & Networking News will be Kathy Kincade, a longtime contributor to PNN and our sister publications Diagnostic Imaging and Telehealth Magazine. She also served as editor of Telemedicine Business News, the predecessor to PNN, and has extensive experience covering the teleradiology and PACS markets. The new editor can be reached at kkincade@mfi.com.
- Search again
- Homepage
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
